found that administration of cyclosporine (a CNI) to SCID-beige mice dramatically increased the metastatic spread of tumor cells, and that this tumor-promoting effect was blocked by coadministration of antibodies to transforming growth factor-β1 (TGF-β1) 6. This evidence concerns the gene TGFB1 and neoplasm.